Sage Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sage Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q4 2024.
  • Sage Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2024 was 61.4M shares, a 2.19% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 61.4M +1.31M +2.19% Dec 31, 2024 10-K 2025-02-11
Q3 2024 61.2M +1.21M +2.01% Sep 30, 2024 10-Q 2024-10-29
Q2 2024 60.9M +1.1M +1.84% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 60.2M +420K +0.7% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 60M +535K +0.9% Dec 31, 2023 10-K 2025-02-11
Q3 2023 60M +474K +0.8% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 59.8M +407K +0.69% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 59.8M +696K +1.18% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 59.5M +572K +0.97% Dec 31, 2022 10-K 2024-02-14
Q3 2022 59.5M +661K +1.12% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 59.4M +618K +1.05% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 59.1M +659K +1.13% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 58.9M +629K +1.08% Dec 31, 2021 10-K 2023-02-16
Q3 2021 58.8M +6.81M +13.1% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 58.8M +6.84M +13.2% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 58.4M +6.49M +12.5% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 58.3M +6.43M +12.4% Dec 31, 2020 10-K 2022-02-24
Q3 2020 52M +207K +0.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 51.9M +466K +0.91% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 51.9M +884K +1.73% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 51.9M +4.99M +10.6% Dec 31, 2019 10-K 2021-02-24
Q3 2019 51.8M +4.99M +10.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 51.5M +4.87M +10.4% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 51M +4.58M +9.85% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 46.9M +4.89M +11.6% Dec 31, 2018 10-K 2020-02-27
Q3 2018 46.8M +9.31M +24.8% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 46.6M +9.18M +24.5% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 46.5M +9.15M +24.5% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 42M +4.78M +12.8% Dec 31, 2017 10-K 2019-02-19
Q3 2017 37.5M +360K +0.97% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 37.4M +5.35M +16.7% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 37.3M +5.27M +16.4% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 37.2M +8.4M +29.1% Dec 31, 2016 10-K 2018-02-22
Q3 2016 37.2M +8.38M +29.1% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 32.1M +3.45M +12% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 32M +6.34M +24.7% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 28.8M +3.2M +12.5% Dec 31, 2015 10-K 2017-02-24
Q3 2015 28.8M +3.2M +12.5% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 28.6M +26.9M +1570% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 25.7M Mar 31, 2015 10-Q 2015-05-15
Q4 2014 25.6M +24M +1479% Dec 31, 2014 10-K 2016-02-29
Q3 2014 25.6M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 1.71M Jun 30, 2014 10-Q 2014-08-14
Q4 2013 1.62M Dec 31, 2013 10-K 2015-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.